Granules India gets tentative USFDA nod for generic version of Mucinex ER Tablets Medical Dialogues Bureau15 Feb 2020 11:00 AM ISTNew Delhi: Drugmaker Granules India Limited recently announced that the company has received tentative approval from the US Food & Drug...
Granules India gets tentative USFDA nod for generic Colchicine capsules Medical Dialogues Bureau12 Feb 2020 2:34 PM ISTNew Delhi: Drug firm Granules India on Tuesday said it has received tentative approval from the US health regulator for its generic Colchicine...
Granules Pharma gets USFDA nod for genetic disorder drug Colchicine Medical Dialogues Bureau8 Feb 2020 10:30 AM IST "The US Food & Drug Administration (USFDA) has approved the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc, a...
Granules India sells entire stake in JV Biocause Pharma Medical Dialogues Bureau6 Feb 2020 1:00 PM ISTNew Delhi: Drugmaker Granules India Ltd recently said it has divested its entire stake in Granules-Biocause Pharmaceutical Co Limited, a...
Granules India arm gets USFDA nod for generic version of Valcyte Medical Dialogues Bureau5 Feb 2020 3:13 PM IST Valganciclovir hydrochloride oral solution is bioequivalent to the reference listed drug product (RLD), Valcyte for Oral Solution, 50mg/mL, OF Roche...
Granules India recalls over 2.3 cr ranitidine tablets from US market Farhat Nasim13 Jan 2020 11:59 AM ISTNew Delhi: Drug firm Granules India is recalling over 2.3 crore ranitidine tablets, used to treat ulcers of the stomach and intestines, from the US...
Granules India gets 2 USFDA observations for Chantilly facility Medical Dialogues Bureau23 Aug 2019 11:46 AM IST"The United States Food and Drug Administration (USFDA) has completed inspection of the facility of Granules Pharmaceuticals Inc, a wholly-owned...
Granules India arm wins USFDA approval for stimulant drug Amphetamine Sulfate tablets Medical Dialogues Bureau7 Aug 2019 9:30 AM ISTAmphetamine Sulfate tablets is a generic version of Arbor Pharmaceuticals LLC's Evekeo tablets in similar strength, it added.New Delhi: Drug firm...
Granules India completes USFDA inspection for Bonthapally facility with one observation Farhat Nasim29 July 2019 10:00 AM ISTGranules India Ltd's Bonthapally facility is one of the world's largest single-site Paracetamol API manufacturing plant by volume. New Delhi: Drug...
Granules India Q1 net profit up 41 percent to Rs 51.7 crore Ruby Khatun Khatun25 July 2018 10:00 AM ISTNew Delhi: Drug firm Granules India reported a 40.73 percent rise in its consolidated net profit at Rs 51.79 crore for the quarter ended on June 30,...
Granules India posts Q2 net profit at Rs 40 crore Ruby Khatun Khatun10 Nov 2017 10:47 AM ISTNew Delhi: Pharma company Granules India reported almost flat consolidated net profit at Rs 40.33 crore for the September quarter of the current...
Granules India gets EIR from USFDA for Vizag OmniChem facility Ruby Khatun Khatun8 Oct 2017 10:01 AM ISTNew Delhi: Drug firm Granules India said it has received Establishment Inspection Report (EIR) from the US health regulator for the OmniChem facility...
